Position in OABI
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$30,090
+$10,971 QoQ
Shares Held
12,232
+0.4% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#80
of 141 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in OABI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHOREO, LLC holds $19,054,830 across 40 Biotechnology names. OABI ranks #39 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,514 | $3,438,199 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,474 | $3,215,830 | |
| 3 | INCY |
Incyte Corp
|
7,759 | $879,560 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,770 | $833,853 | |
| 5 | ARGX |
Argenx SE
|
809 | $750,565 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
3,045 | $733,753 | |
| 7 | ACAD |
Acadia Pharmaceuticals Inc
|
27,134 | $686,490 | |
| 8 | GMAB |
Genmab A/S
|
24,930 | $684,827 |
All Filings in OABI
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,090 | 12,232 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $19,119 | 12,178 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $19,334 | 10,451 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $19,808 | 12,380 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $20,516 | 11,791 | Shares | Sole | 2025-08-13 | |
| 2024-12-31 | $40,398 | 11,412 | Shares | Sole | 2025-01-27 | |
| No filing history on record for this holder in this stock. | ||||||